J

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076

Watchlist Manager
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
Watchlist
Price: 37.7 CNY 0.08% Market Closed
Market Cap: 11.9B CNY

Intrinsic Value

The intrinsic value of one Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 37.7 CNY, Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd.

Explain Valuation
Compare Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd to

Fundamental Analysis

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Current Assets 2.7B
Cash & Short-Term Investments 1.1B
Receivables 696m
Other Current Assets 967m
Non-Current Assets 3.9B
Long-Term Investments 242m
PP&E 2.6B
Intangibles 589m
Other Non-Current Assets 530m
Current Liabilities 2.1B
Accounts Payable 597m
Accrued Liabilities 55m
Short-Term Debt 1.1B
Other Current Liabilities 259m
Non-Current Liabilities 1.5B
Long-Term Debt 1.4B
Other Non-Current Liabilities 179m
Efficiency

Free Cash Flow Analysis
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Revenue
1.9B CNY
Cost of Revenue
-633.8m CNY
Gross Profit
1.3B CNY
Operating Expenses
-678.7m CNY
Operating Income
587.2m CNY
Other Expenses
-88.6m CNY
Net Income
498.7m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Operating Margin
Exceptional Gross Margin
ROIC is Increasing
ROE is Increasing
hidden
Profitability
Score

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
hidden
Solvency
Score

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Wall Street analysts forecast Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is 51.15 CNY with a low forecast of 50.64 CNY and a high forecast of 52.65 CNY.

Lowest
Price Target
50.64 CNY
34% Upside
Average
Price Target
51.15 CNY
36% Upside
Highest
Price Target
52.65 CNY
40% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock?

The intrinsic value of one Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY.

Is Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 37.7 CNY, Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is hidden .

Back to Top